PHRM.CN Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: May 02, 2025
Report Source: 2025 3rd Quarter Report
Pharmather Holdings Ltd. Stock Analysis PHRM.CN
PharmaTher Holdings Ltd. is a specialty psychedelic pharmaceutical company, which engages in the research, development and commercialization of ketamine and novel microneedle patches for delivering psychedelics to treat neuropsychiatric, neurodegenerative, and pain disorders. The company is headquartered in Toronto, Ontario. The company went IPO on 2020-10-09. The firm develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The firm is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases. The firm is in the development of programs for the delivery of KETARX (ketamine) in a patch and on-body pump for mental health, pain and medical countermeasures indications.
Read More Pharmather Holdings Ltd (PHRM.CN) Chart
Key Statistics of Pharmather Holdings Ltd (PHRM.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.07Volume
104.69KP/E Ratio (TTM)
-52 Week Range
Market Cap
7.74MAvg. Volume
292.90KDividend Yield
-Financial Metrics & Statements of Pharmather Holdings Ltd (PHRM.CN)
FAQ's for Pharmather Holdings Ltd (PHRM.CN)
- According to Musaffa’s Shariah screening methodology, Pharmather Holdings Ltd (PHRM.CN) is currently classified as NOT HALAL as of May 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.